Cancer Biomarkers


Malignant growth biomarkers also known as cancer biomarkers (CB) are bimolecular created either by the tumor cells or by different cells of the body in light of the tumor, and CB could be utilized as screening/early location instrument of disease, demonstrative, prognostic, or indicator for the general result of a patient. Besides, malignancy biomarkers may distinguish subpopulations of patients who are well on the way to react to a given treatment. Biomarkers can be qualities, quality items, explicit cells, particles, catalysts, or chemicals which can be identified in blood, pee, tissues, or other body liquid.



 


  • Cell Lung Cancer Adhesion Molecules
  • Genetic Mutations
  • Gene Silencing
  • Chromosomal Changes
  • Genomic Instability

Related Conference of Cancer Biomarkers

November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
November 28-29, 2024

14th World Congress on Breast Cancer

Paris, France
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE
December 11-12, 2024

34th Experts Meet On Cancer Research & Therapy

Paris, France
December 12-13, 2024

44th Euro Congress on Cancer Science & Therapy

Rome, Italy
March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK
March 24-25, 2025

10th World Conference on Breast and Cervical Cancer

Paris, France
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands

Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in